Invention Grant
- Patent Title: Nitrogen-containing heterocyclic compound
-
Application No.: US15291769Application Date: 2016-10-12
-
Publication No.: US09675597B2Publication Date: 2017-06-13
- Inventor: Masami Yamada , Shinkichi Suzuki , Takahiro Sugimoto , Minoru Nakamura , Hiroki Sakamoto , Makoto Kamata
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Hamre, Schumann, Mueller & Larson, P.C.
- Priority: JP2014-089585 20140423
- Main IPC: C07D209/46
- IPC: C07D209/46 ; C07D403/10 ; C07D405/14 ; C07D403/04 ; C07D401/10 ; C07D401/14 ; A61K31/4439 ; A61K31/4035 ; A61K31/4155
Abstract:
The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like.The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.
Public/Granted literature
- US20170027921A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND Public/Granted day:2017-02-02
Information query
